Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update

Go back to Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update
SmartPros Ltd. (NASDAQ: SPRO) Delayed: 1.14 --0 (-0%)
Previous Close $1.14    52 Week High $3.85 
Open $1.14    52 Week Low $1.25 
Day High $1.14    P/E N/A 
Day Low $1.14    EPS $-0.28 
Volume 629